Colchicine to reduce coronavirus disease-19-related inflammation and cardiovascular complications in high-risk patients post-acute infection with SARS-COV-2-a study protocol for a randomized controlled trial.

Shani S ThankachenNiveditha DevasenapathyAbhinav BassiArpita GhoshSumaiya ArfinBalaji GummidiAneesh BasheerAshfak BangiDibakar SahuAshish BhallaMerlin BlessonManish JainVivekananda Jha

Published in: Trials (2024)

gov with registration CTRI/2021/11/038234 dated November 24, 2021.

Keyphrases

sars cov
coronavirus disease
end stage renal disease
ejection fraction
newly diagnosed
respiratory syndrome coronavirus
oxidative stress
liver failure
risk factors
intensive care unit
patient reported outcomes
aortic dissection
acute respiratory distress syndrome